HOME DM-BAT: home-based diabetes-modified behavioral activation treatment for low-income seniors with type 2 diabetes—study protocol for a randomized controlled trial

Abstract Background About 13% of African Americans and 13% of Hispanics have diabetes, compared to 8% of non-Hispanic Whites (NHWs). This is more pronounced in the elderly where about 25–30% of those aged 65 and older have diabetes. Studies have found associations between social determinants of heal...

Full description

Bibliographic Details
Main Authors: Leonard E. Egede, Tatiana M. Davidson, Rebecca G. Knapp, Rebekah J. Walker, Joni S. Williams, Clara E. Dismuke, Aprill Z. Dawson
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-021-05744-1
_version_ 1819006310496075776
author Leonard E. Egede
Tatiana M. Davidson
Rebecca G. Knapp
Rebekah J. Walker
Joni S. Williams
Clara E. Dismuke
Aprill Z. Dawson
author_facet Leonard E. Egede
Tatiana M. Davidson
Rebecca G. Knapp
Rebekah J. Walker
Joni S. Williams
Clara E. Dismuke
Aprill Z. Dawson
author_sort Leonard E. Egede
collection DOAJ
description Abstract Background About 13% of African Americans and 13% of Hispanics have diabetes, compared to 8% of non-Hispanic Whites (NHWs). This is more pronounced in the elderly where about 25–30% of those aged 65 and older have diabetes. Studies have found associations between social determinants of health (SDoH) and increased incidence, prevalence, and burden of diabetes; however, few interventions have accounted for the context in which the elderly live by addressing SDoH. Specifically, psychosocial factors (such as cognitive dysfunction, functional impairment, and social isolation) impacting this population may be under-addressed due to numerous medical concerns addressed during the clinical visit. The long-term goal of the project is to identify strategies to improve glycemic control and reduce diabetes complications and mortality in African Americans and Hispanics/Latinos with type 2 diabetes. Methods This is a 5-year prospective, randomized clinical trial, which will test the effectiveness of a home-based diabetes-modified behavioral activation treatment for low-income, minority seniors with type 2 diabetes mellitus (T2DM) (HOME DM-BAT). Two hundred, aged 65 and older and with an HbA1c ≥8%, will be randomized into one of two groups: (1) an intervention using in-home, nurse telephone-delivered diabetes education, and behavioral activation or (2) a usual care group using in-home, nurse telephone-delivered, health education/supportive therapy. Participants will be followed for 12 months to ascertain the effect of the intervention on glycemic control, blood pressure, and low-density lipoprotein (LDL) cholesterol. The primary hypothesis is low-income, minority seniors with poorly controlled type 2 diabetes randomized to HOME DM-BAT will have significantly greater improvements in clinical outcomes at 12 months of follow-up compared to usual care. Discussion Results from this study will provide important insight into the effectiveness of a home-based diabetes-modified behavioral activation treatment for low-income, minority seniors with uncontrolled type 2 diabetes mellitus and inform strategies to improve glycemic control and reduce diabetes complications in minority elderly with T2DM. Trial registration ClinicalTrials.gov NCT04203147 ). Registered on December 18, 2019, with the National Institutes of Health Clinical Trials Registry.
first_indexed 2024-12-21T00:06:39Z
format Article
id doaj.art-529459c191324a39a9d77c88c034bd92
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-12-21T00:06:39Z
publishDate 2021-11-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-529459c191324a39a9d77c88c034bd922022-12-21T19:22:27ZengBMCTrials1745-62152021-11-0122111110.1186/s13063-021-05744-1HOME DM-BAT: home-based diabetes-modified behavioral activation treatment for low-income seniors with type 2 diabetes—study protocol for a randomized controlled trialLeonard E. Egede0Tatiana M. Davidson1Rebecca G. Knapp2Rebekah J. Walker3Joni S. Williams4Clara E. Dismuke5Aprill Z. Dawson6Department of Medicine, Division of General Internal Medicine, Medical College of WisconsinCollege of Nursing, Medical University of South CarolinaDepartment of Public Health Services, College of Medicine, Medical University of South CarolinaDepartment of Medicine, Division of General Internal Medicine, Medical College of WisconsinDepartment of Medicine, Division of General Internal Medicine, Medical College of WisconsinHealth Economics Resource Center, VA Palo Alto Healthcare SystemDepartment of Medicine, Division of General Internal Medicine, Medical College of WisconsinAbstract Background About 13% of African Americans and 13% of Hispanics have diabetes, compared to 8% of non-Hispanic Whites (NHWs). This is more pronounced in the elderly where about 25–30% of those aged 65 and older have diabetes. Studies have found associations between social determinants of health (SDoH) and increased incidence, prevalence, and burden of diabetes; however, few interventions have accounted for the context in which the elderly live by addressing SDoH. Specifically, psychosocial factors (such as cognitive dysfunction, functional impairment, and social isolation) impacting this population may be under-addressed due to numerous medical concerns addressed during the clinical visit. The long-term goal of the project is to identify strategies to improve glycemic control and reduce diabetes complications and mortality in African Americans and Hispanics/Latinos with type 2 diabetes. Methods This is a 5-year prospective, randomized clinical trial, which will test the effectiveness of a home-based diabetes-modified behavioral activation treatment for low-income, minority seniors with type 2 diabetes mellitus (T2DM) (HOME DM-BAT). Two hundred, aged 65 and older and with an HbA1c ≥8%, will be randomized into one of two groups: (1) an intervention using in-home, nurse telephone-delivered diabetes education, and behavioral activation or (2) a usual care group using in-home, nurse telephone-delivered, health education/supportive therapy. Participants will be followed for 12 months to ascertain the effect of the intervention on glycemic control, blood pressure, and low-density lipoprotein (LDL) cholesterol. The primary hypothesis is low-income, minority seniors with poorly controlled type 2 diabetes randomized to HOME DM-BAT will have significantly greater improvements in clinical outcomes at 12 months of follow-up compared to usual care. Discussion Results from this study will provide important insight into the effectiveness of a home-based diabetes-modified behavioral activation treatment for low-income, minority seniors with uncontrolled type 2 diabetes mellitus and inform strategies to improve glycemic control and reduce diabetes complications in minority elderly with T2DM. Trial registration ClinicalTrials.gov NCT04203147 ). Registered on December 18, 2019, with the National Institutes of Health Clinical Trials Registry.https://doi.org/10.1186/s13063-021-05744-1DiabetesElderlySeniorsOlder adultsEducationBehavioral activation
spellingShingle Leonard E. Egede
Tatiana M. Davidson
Rebecca G. Knapp
Rebekah J. Walker
Joni S. Williams
Clara E. Dismuke
Aprill Z. Dawson
HOME DM-BAT: home-based diabetes-modified behavioral activation treatment for low-income seniors with type 2 diabetes—study protocol for a randomized controlled trial
Trials
Diabetes
Elderly
Seniors
Older adults
Education
Behavioral activation
title HOME DM-BAT: home-based diabetes-modified behavioral activation treatment for low-income seniors with type 2 diabetes—study protocol for a randomized controlled trial
title_full HOME DM-BAT: home-based diabetes-modified behavioral activation treatment for low-income seniors with type 2 diabetes—study protocol for a randomized controlled trial
title_fullStr HOME DM-BAT: home-based diabetes-modified behavioral activation treatment for low-income seniors with type 2 diabetes—study protocol for a randomized controlled trial
title_full_unstemmed HOME DM-BAT: home-based diabetes-modified behavioral activation treatment for low-income seniors with type 2 diabetes—study protocol for a randomized controlled trial
title_short HOME DM-BAT: home-based diabetes-modified behavioral activation treatment for low-income seniors with type 2 diabetes—study protocol for a randomized controlled trial
title_sort home dm bat home based diabetes modified behavioral activation treatment for low income seniors with type 2 diabetes study protocol for a randomized controlled trial
topic Diabetes
Elderly
Seniors
Older adults
Education
Behavioral activation
url https://doi.org/10.1186/s13063-021-05744-1
work_keys_str_mv AT leonardeegede homedmbathomebaseddiabetesmodifiedbehavioralactivationtreatmentforlowincomeseniorswithtype2diabetesstudyprotocolforarandomizedcontrolledtrial
AT tatianamdavidson homedmbathomebaseddiabetesmodifiedbehavioralactivationtreatmentforlowincomeseniorswithtype2diabetesstudyprotocolforarandomizedcontrolledtrial
AT rebeccagknapp homedmbathomebaseddiabetesmodifiedbehavioralactivationtreatmentforlowincomeseniorswithtype2diabetesstudyprotocolforarandomizedcontrolledtrial
AT rebekahjwalker homedmbathomebaseddiabetesmodifiedbehavioralactivationtreatmentforlowincomeseniorswithtype2diabetesstudyprotocolforarandomizedcontrolledtrial
AT joniswilliams homedmbathomebaseddiabetesmodifiedbehavioralactivationtreatmentforlowincomeseniorswithtype2diabetesstudyprotocolforarandomizedcontrolledtrial
AT claraedismuke homedmbathomebaseddiabetesmodifiedbehavioralactivationtreatmentforlowincomeseniorswithtype2diabetesstudyprotocolforarandomizedcontrolledtrial
AT aprillzdawson homedmbathomebaseddiabetesmodifiedbehavioralactivationtreatmentforlowincomeseniorswithtype2diabetesstudyprotocolforarandomizedcontrolledtrial